Whitehawk Therapeutics, Inc.
WHWK
$1.90
$0.031.60%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 499.58% | -45.65% | 13.97% | 20.26% | -12.42% |
| Total Depreciation and Amortization | 21.28% | 0.00% | -4.08% | -2.00% | 13.64% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -5,001.03% | -25.39% | -8.73% | -23.14% | 21.90% |
| Change in Net Operating Assets | -48.56% | 125.76% | -296.83% | 159.11% | -223.77% |
| Cash from Operations | 21.19% | 4.04% | -71.31% | 53.41% | -103.78% |
| Capital Expenditure | -196.24% | 1.06% | 65.25% | 26.79% | 9.44% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 10.32% | 152.59% | 274.03% | -126.83% | 152.95% |
| Cash from Investing | 779.45% | 158.27% | 242.40% | -133.83% | 189.26% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 192,251.92% | -- | -100.00% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -482,300.00% | -- | 100.00% | 30.00% | 70.59% |
| Cash from Financing | 179,524.53% | -- | -100.00% | 970.00% | -112.50% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 10,749.97% | 82.39% | 16.13% | -38.79% | -53.98% |